This observation was further validated and refined in a separate study, with the additional specification that reductions in nuclear PTHrP in primary tumors were associated with a poorer prognosis and that the PTHrP levels in aggressive breast tumors were lower than normal breast epithelial tissue, implying a protective role of nuclear PTHrP in primary breast tumors and patient outcomes [25]. Here, PTHLH is linked to breast neoplasm.